Gossamer Bio, Inc. (GOSS) has 20 tenedores institucionales e internos conocidos registrados. El mayor tenedor es Omega Fund V, L.P. con 6,553,416 acciones. Otros tenedores destacados incluyen Hasnain Faheem y Aranda Richard.
En los últimos 12 meses, los internos han realizado 16 transacciones en GOSS acciones — 10 compras (valoradas en $938.4K) y 0 ventas (valoradas en RSU Award). Las compras internas han superado las ventas durante este período, lo que puede señalar confianza en las perspectivas de la empresa.
GOSS Participación de Insiders
Principal Titular
Omega Fund V, L.P.
6,553,416 acciones
Compras (12 meses)
10
$938.4K valor
Ventas (12 meses)
0
$0.00 valor
Actividad de Transacciones (12 meses)
Principales Titulares Internos
| # |
Nombre |
Cargo |
Acciones en Propiedad |
Última Declaración |
Tamaño Relativo |
| 1 |
Omega Fund V, L.p. |
10 Percent Owner |
6,553,416 |
2019-09-23 |
|
| 2 |
Hasnain Faheem |
President & CEO |
837,793 |
2026-01-05 |
|
| 3 |
Aranda Richard |
Chief Medical Officer |
463,106 |
2026-01-05 |
|
| 4 |
Peterson Caryn |
EVP, Regulatory Affairs |
440,000 |
2025-03-06 |
|
| 5 |
Christian Waage |
EVP, Tech Ops and Admin |
440,000 |
2025-03-06 |
|
| 6 |
Giraudo Bryan |
COO/cfo |
389,737 |
2026-01-05 |
|
| 7 |
Smith Robert Paul Jr |
Chief Commercial Officer |
260,898 |
2026-01-05 |
|
| 8 |
Salter-cid Luisa |
Chief Scientific Officer |
206,065 |
2021-03-25 |
|
| 9 |
Gujrathi Sheila |
President & CEO |
189,500 |
2020-02-19 |
|
| 10 |
Cox Russell J. |
Director |
115,000 |
2025-06-26 |
|
| 11 |
Milligan Sandra |
Director |
115,000 |
2025-06-26 |
|
| 12 |
Drynan Skye |
Director |
115,000 |
2025-06-26 |
|
| 13 |
Quisel John D |
Director |
115,000 |
2025-06-26 |
|
| 14 |
Daniel Thomas O |
Director |
115,000 |
2025-06-26 |
|
| 15 |
Nathan Steven D |
Director |
115,000 |
2025-06-26 |
|
| 16 |
Carter Laura |
Chief Scientific Officer |
76,263 |
2023-03-20 |
|
| 17 |
Dupont Jakob |
Chief Medical Officer |
46,500 |
2020-02-19 |
|
| 18 |
Burow Kristina |
Director |
35,000 |
2023-06-09 |
|
| 19 |
Gala Renee D |
Director |
35,000 |
2023-06-09 |
|
| 20 |
Bilenker Joshua H. |
Director |
30,000 |
2022-07-15 |
|
Transacciones Recientes (últimos 12 meses)
| Fecha |
Nombre |
Cargo |
Tipo |
Acciones |
Precio |
Valor |
| 2026-03-19 |
Smith Robert Paul Jr |
Chief Commercial Officer |
Devolución de Acciones |
562,500 |
$2.88 |
$1.62M |
| 2026-03-19 |
Aranda Richard |
Chief Medical Officer |
Devolución de Acciones |
157,500 |
$1.21 |
$190.58K |
| 2026-03-19 |
Peterson Caryn |
EVP, Regulatory Affairs |
Devolución de Acciones |
125,000 |
$0.84 |
$104.75K |
| 2026-03-19 |
Giraudo Bryan |
COO/cfo |
Devolución de Acciones |
211,500 |
$2.16 |
$456.84K |
| 2026-03-19 |
Christian Waage |
EVP, Tech Ops and Admin |
Devolución de Acciones |
70,000 |
$1.36 |
$95.2K |
| 2026-03-19 |
Hasnain Faheem |
President & CEO |
Devolución de Acciones |
47,000 |
$12.10 |
$568.7K |
| 2026-01-02 |
Smith Robert Paul Jr |
Chief Commercial Officer |
Concesión de RSU |
93,750 |
- |
- |
| 2026-01-02 |
Aranda Richard |
Chief Medical Officer |
Concesión de RSU |
93,750 |
- |
- |
| 2026-01-02 |
Giraudo Bryan |
COO/cfo |
Concesión de RSU |
115,750 |
- |
- |
| 2026-01-02 |
Hasnain Faheem |
President & CEO |
Concesión de RSU |
280,000 |
- |
- |
| 2025-06-25 |
Nathan Steven D |
Director |
Concesión de RSU |
115,000 |
$1.36 |
$156.4K |
| 2025-06-25 |
Drynan Skye |
Director |
Concesión de RSU |
115,000 |
$1.36 |
$156.4K |
| 2025-06-25 |
Milligan Sandra |
Director |
Concesión de RSU |
115,000 |
$1.36 |
$156.4K |
| 2025-06-25 |
Quisel John D |
Director |
Concesión de RSU |
115,000 |
$1.36 |
$156.4K |
| 2025-06-25 |
Daniel Thomas O |
Director |
Concesión de RSU |
115,000 |
$1.36 |
$156.4K |
| 2025-06-25 |
Cox Russell J. |
Director |
Concesión de RSU |
115,000 |
$1.36 |
$156.4K |
